| Title |
When we enhance cognition with Adderall, do we sacrifice creativity? A preliminary study
|
|---|---|
| Published in |
Psychopharmacology, November 2008
|
| DOI | 10.1007/s00213-008-1369-3 |
| Pubmed ID | |
| Authors |
Martha J. Farah, Caroline Haimm, Geena Sankoorikal, Anjan Chatterjee |
| Abstract |
Adderall (mixed amphetamine salts) is used by healthy normal individuals to enhance attention. Research with healthy normal participants and those with attention deficit hyperactivity disorder indicate a possible inverse relationship between attentional function and creativity. This raises the possibility that Adderall could decrease creativity in people using it for cognitive enhancement. |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 2 | 100% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 227 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United States | 11 | 5% |
| Germany | 5 | 2% |
| United Kingdom | 5 | 2% |
| Sweden | 1 | <1% |
| New Zealand | 1 | <1% |
| Switzerland | 1 | <1% |
| Unknown | 203 | 89% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 49 | 22% |
| Student > Master | 39 | 17% |
| Student > Ph. D. Student | 33 | 15% |
| Researcher | 26 | 11% |
| Student > Doctoral Student | 13 | 6% |
| Other | 45 | 20% |
| Unknown | 22 | 10% |
| Readers by discipline | Count | As % |
|---|---|---|
| Psychology | 76 | 33% |
| Medicine and Dentistry | 23 | 10% |
| Agricultural and Biological Sciences | 22 | 10% |
| Social Sciences | 17 | 7% |
| Neuroscience | 10 | 4% |
| Other | 48 | 21% |
| Unknown | 31 | 14% |
Attention Score in Context
This research output has an Altmetric Attention Score of 58. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 06 December 2022.
All research outputs
#647,542
of 23,511,526 outputs
Outputs from Psychopharmacology
#164
of 5,408 outputs
Outputs of similar age
#1,238
of 88,545 outputs
Outputs of similar age from Psychopharmacology
#1
of 39 outputs
Altmetric has tracked 23,511,526 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,408 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 10.8. This one has done particularly well, scoring higher than 96% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 88,545 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 98% of its contemporaries.
We're also able to compare this research output to 39 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 97% of its contemporaries.